Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan;140(1):176-83.
doi: 10.1016/j.ygyno.2015.11.011. Epub 2015 Nov 7.

Chemotherapy-induced peripheral neuropathy: Current status and progress

Jamie R Brewer  1 , Gladys Morrison  2 , M Eileen Dolan  2 , Gini F Fleming  3
Affiliations
Review

Chemotherapy-induced peripheral neuropathy: Current status and progress

Jamie R Brewer et al. Gynecol Oncol. 2016 Jan.

Abstract

As there are increasing numbers of cancer survivors, more attention is being paid to the long term unwanted effects patients may experience as a result of their treatment and the impact these side effects can have on their quality of life. Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most common long-term toxicities from chemotherapy. In this review we will briefly review the clinical presentation, evaluation and management of chemotherapy-induced peripheral neuropathy, with a focus on CIPN related to platinum and taxane agents. We will then discuss current clinical models of peripheral neuropathy and ongoing research to better understand CIPN and develop potential treatment options.

Keywords: Chemotherapy; Neuropathy; Toxicity.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Potential of iPSC derived models
Recent technological development allows for the development of induced pluripotent stem cells (iPSCs) and differentiation to neurons for drug development, mechanistic evaluation and toxicity testing to ultimately improve health.
See this image and copyright information in PMC

References

    1. Alberti P, et al. Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin. Ann Oncol. 2014;25(1):257–64. - PMC - PubMed
    1. Tew WP, et al. Breast and ovarian cancer in the older woman. J Clin Oncol. 2014;32(24):2553–61. - PubMed
    1. Lichtman SM, et al. Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840. Ann Oncol. 2012;23(3):632–8. - PMC - PubMed
    1. Park SB, et al. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin. 2013;63(6):419–37. - PubMed
    1. Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249(1):9–17. - PubMed

Publication types

MeSH terms